Update on the Neuropsychiatry of Substance Use Disorders

被引：2

作者：

Kolodner, George ^{[1
,2
]}

Koliatsos, Vassilis E. ^{[3
,4
,5
,6
]}

机构：

[1] Kolmac Outpatient Recovery Ctr, 3919 Natl Dr, Burtonsville, MD 20910 USA

[2] Univ Maryland, Sch Med, Georgetown Univ, College Pk, MD 20742 USA

[3] Johns Hopkins Univ, Sch Med, Dept Pathol Neuropathol, Baltimore, MD USA

[4] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA

[5] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA

[6] Sheppard & Enoch Pratt Hosp, Neuropsychiat Program, Sheppard Pratt Hlth Syst, 6501 North Charles St, Baltimore, MD 21204 USA

来源：

PSYCHIATRIC CLINICS OF NORTH AMERICA | 2020年 / 43卷 / 02期

关键词：

Substance use disorders; Opioids; Cannabis; Drugs; Craving; Buprenorphine; Naltrexone; Acamprosate; RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; CANNABIS; ABSTINENCE; METHADONE;

D O I：

10.1016/j.psc.2020.02.011

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

This article reviews some of the recent discoveries about how neurobiological processes contribute to the understanding and treatment of substance use disorders. Particular focus is given to cannabis, opioids, and designer drugs. Important areas addressed include triggers and cravings, the central roles of dopamine and stress, and the endocannabinoid system. Clinical relevance of these findings for withdrawal management and relapse prevention is discussed. Also highlighted are issues related to the opioid epidemic and consequences both of continuing federal prohibition of cannabis as well as its state-by-state relaxation.

引用

收藏

页码：291 / +

页数：15

相关论文

共 50 条

[21] Neuropathology of substance use disorders [J].

Jean Lud Cadet ;

Veronica Bisagno ;

Christopher Mark Milroy .

Acta Neuropathologica, 2014, 127 :91-107

[22] Neuropathology of substance use disorders [J].

Cadet, Jean Lud ;

Bisagno, Veronica ;

Milroy, Christopher Mark .

ACTA NEUROPATHOLOGICA, 2014, 127 (01) :91-107

[23] Prevention of substance use disorders [J].

Arnaud, Nicolas ;

Thomasius, Rainer .

ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 2020, 48 (05) :381-392

[24] COVID-19 and persons with substance use disorders: Inequities and mitigation strategies [J].

Melamed, Osnat C. ;

Hauck, Tanya S. ;

Buckley, Leslie ;

Selby, Peter ;

Mulsant, Benoit H. .

SUBSTANCE ABUSE, 2020, 41 (03) :286-291

[25] Pharmacotherapies for co-occurring substance use and bipolar disorders: A systematic review [J].

Coles, Alexandria S. ;

Sasiadek, Julia ;

George, Tony P. .

BIPOLAR DISORDERS, 2019, 21 (07) :595-610

[26] Substance use disorders among immigrants in the United States: A research update [J].

Salas-Wright, Christopher P. ;

Vaughn, Michael G. ;

Goings, Trenette T. Clark ;

Cordova, David ;

Schwartz, Seth J. .

ADDICTIVE BEHAVIORS, 2018, 76 :169-173

[27] An Update on the Role of Common Genetic Variation Underlying Substance Use Disorders [J].

Emma C. Johnson ;

Yoonhoo Chang ;

Arpana Agrawal .

Current Genetic Medicine Reports, 2020, 8 :35-46

[28] Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders [J].

Navarrete, Francisco ;

Garcia-Gutierrez, Maria Salud ;

Gasparyan, Ani ;

Austrich-Olivares, Amaya ;

Manzanares, Jorge .

FRONTIERS IN PHARMACOLOGY, 2021, 12

[29] Medications for substance use disorders (SUD): emerging approaches [J].

Butelman, Eduardo R. ;

Kreek, Mary Jeanne .

EXPERT OPINION ON EMERGING DRUGS, 2017, 22 (04) :301-315

[30] Rapid Cognitive Screening of Patients With Substance Use Disorders [J].

Copersino, Marc L. ;

Fals-Stewart, William ;

Fitzmaurice, Garrett ;

Schretlen, David J. ;

Sokoloff, Jody ;

Weiss, Roger D. .

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2009, 17 (05) :337-344

← 1 2 3 4 5 →